News
MedPage Today on MSN5d
Novel IL-7 Receptor Antagonist Shows Promise in Ulcerative ColitisLusvertikimab selectively inhibits IL-7 but not the thymic stromal lymphopoietin (TSLP) axis, Bourreille told attendees. A ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback